Zomedica Pharmaceuticals Corp. (NYSE: ZOM) Starts Presentation at 30th Annual ROTH Conference
Zomedica (NYSE: ZOM) is a veterinary diagnostic and pharmaceutical company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit the company’s website at www.ZOMEDICA.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that…







